Beyond Air is a biotechnology company that focuses on the development of drugs for the treatment of lung infections.
Beyond Air has raised $5.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in January 2026.
Beyond Air's investors include Avenue Capital Group, Streeterville Capital.
Beyond Air is headquartered in Garden City, United States.
Beyond Air is a biotechnology company that focuses on the development of drugs for the treatment of lung infections.
Beyond Air is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Beyond Air — Funding & Investors." VCBacked, January 14, 2026, https://www.vcbacked.co/company/beyond-air. Accessed November 14, 2026.
VCBacked. (2026). Beyond Air — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/beyond-air
{{cite web |title=Beyond Air — Funding & Investors |url=https://www.vcbacked.co/company/beyond-air |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Beyond Air? Request a listing update